Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers
Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immune checkpoint inhibitors. Cancer-associated fibroblasts (CAFs) are an important part of the tumor microenvironment contributing ...
Jan 23, 2023
0
7